10/18/2024

Janusmed sex and gender

Janusmed sex and gender – Bendroflumethiazide

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Bendroflumethiazide

Bendroflumethiazide

Class : A

Show all info

Print

Contact us

  1. MRC trial of treatment of mild hypertension: principal results Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985;291:97-104.

  2. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet. 1991;2:539-543.

  3. Ramsay LE, Boyle P, Ramsay MH. Factors influencing serum potassium in treated hypertension. Q J Med. 1977;46:401-10.

  4. Toner JM, Ramsay LE. Thiazide-induced hypokalaemia; prevalence higher in women. Br J Clin Pharmacol. 1984;18:449-52.

  5. Ahlstrand C, Tiselius HG, Larsson L, Hellgren E. Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers. Br J Urol. 1984;56:255-62.

  6. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2018 [cited 2019-03-08.]

  1. MRC trial of treatment of mild hypertension: principal results Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985;291:97-104.
  2. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Lancet. 1991;2:539-543.
  3. Ramsay LE, Boyle P, Ramsay MH. Factors influencing serum potassium in treated hypertension. Q J Med. 1977;46:401-10.
  4. Toner JM, Ramsay LE. Thiazide-induced hypokalaemia; prevalence higher in women. Br J Clin Pharmacol. 1984;18:449-52.
  5. Ahlstrand C, Tiselius HG, Larsson L, Hellgren E. Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers. Br J Urol. 1984;56:255-62.
  6. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2018 [cited 2019-03-08.]